Simultaneous inhibition of the estrogen receptor and 6-phosphofructo-2-kinase (PFKFB3) for the treatment of ER+ breast cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2049-3002
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Simultaneous inhibition of the estrogen receptor and 6-phosphofructo-2-kinase (PFKFB3) for the treatment of ER+ breast cancer ; volume:2 ; number:1 ; day:28 ; month:5 ; year:2014 ; pages:1 ; date:5.2014
Cancer & metabolism ; 2, Heft 1 (28.5.2014), 1, 5.2014
- Urheber
-
Imbert-Fernandez, Yoannis
- Beteiligte Personen und Organisationen
-
Telang, Sucheta
Chesney, Jason
SpringerLink (Online service)
- DOI
-
10.1186/2049-3002-2-S1-P29
- URN
-
urn:nbn:de:1111-201605193933
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Imbert-Fernandez, Yoannis
- Telang, Sucheta
- Chesney, Jason
- SpringerLink (Online service)
Ähnliche Objekte (12)
Src kinase inhibition promotes the chondrocyte phenotype
Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer
Estrogen receptor signaling regulates the expression of the breast tumor kinase in breast cancer cells
Estrogen modulates serotonin effects on vasoconstriction through Src inhibition
Inhibition of pterygium cell fibrosis by the Rho kinase inhibitor
Exosome markers of LRRK2 kinase inhibition
The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy
The protein kinase CK2 catalytic domain from Plasmodium falciparum: crystal structure, tyrosine kinase activity and inhibition
Autophagy inhibition improves the cytotoxic effects of receptor tyrosine kinase inhibitors
The therapeutic target of estrogen receptor-alpha36 in estrogen-dependent tumors
Inhibition of PI3 kinase isoform p110α suppresses neuroblastoma growth and induces the reduction of Anaplastic Lymphoma Kinase
The estrogen-gallstone connection: uncovering the pathways
Src kinase inhibition promotes the chondrocyte phenotype
Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer
Estrogen receptor signaling regulates the expression of the breast tumor kinase in breast cancer cells
Estrogen modulates serotonin effects on vasoconstriction through Src inhibition
Inhibition of pterygium cell fibrosis by the Rho kinase inhibitor
Exosome markers of LRRK2 kinase inhibition
The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy
The protein kinase CK2 catalytic domain from Plasmodium falciparum: crystal structure, tyrosine kinase activity and inhibition
Autophagy inhibition improves the cytotoxic effects of receptor tyrosine kinase inhibitors
The therapeutic target of estrogen receptor-alpha36 in estrogen-dependent tumors
Inhibition of PI3 kinase isoform p110α suppresses neuroblastoma growth and induces the reduction of Anaplastic Lymphoma Kinase
The estrogen-gallstone connection: uncovering the pathways
Src kinase inhibition promotes the chondrocyte phenotype
Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer
Estrogen receptor signaling regulates the expression of the breast tumor kinase in breast cancer cells
Estrogen modulates serotonin effects on vasoconstriction through Src inhibition
Inhibition of pterygium cell fibrosis by the Rho kinase inhibitor
Exosome markers of LRRK2 kinase inhibition
The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy
The protein kinase CK2 catalytic domain from Plasmodium falciparum: crystal structure, tyrosine kinase activity and inhibition
Autophagy inhibition improves the cytotoxic effects of receptor tyrosine kinase inhibitors
The therapeutic target of estrogen receptor-alpha36 in estrogen-dependent tumors
Inhibition of PI3 kinase isoform p110α suppresses neuroblastoma growth and induces the reduction of Anaplastic Lymphoma Kinase